Phase 2A/B protective efficacy of plasmodium vivax CS derived protein formulated with montanide ISA 51

Authors
Category Primary study
JournalAmerican Journal of Tropical Medicine and Hygiene
Year 2015
This article has no abstract
Epistemonikos ID: df85c62a46c57f5024f3a4d49146a62d65224a01
First added on: Feb 08, 2025